Skip to main content
For COVID-19 vaccine updates, please
review our information guide
and
sign up for Connect
. Continue your routine care with us by scheduling an
in-person appointment
or
Video Visit
.
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Jill Roberts Center for Inflammatory Bowel Disease
Explore this Website
Home
About Us
Toggle menu options
Clinical Staff
Research Staff
Contact Us
Newsworthy
Toggle menu options
News and Announcements
Patient Care
Toggle menu options
Clinical Services
FAQs
For Your Visit
COVID-19 Information
Nutrition Science
Toggle menu options
Nutrition FAQs
Food Intolerances
Research and Clinical Trials
Toggle menu options
Clinical Trials
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Newsworthy
Patient Care
Nutrition Science
Research and Clinical Trials
Home
Publications
Publications
Clinical Trials
Publications
Publications
Found 63 results
Author
Title
Type
[
Year
]
2019
Castellanos JG
,
Longman RS
. 2019.
The balance of power: innate lymphoid cells in tissue inflammation and repair.
.
J Clin Invest. 129(7):2640-2650.
Battat R
,
Ma C
,
Jairath V
,
Khanna R
,
Feagan BG
. 2019.
Benefit-Risk Assessment of Vedolizumab in the Treatment of Crohn's Disease and Ulcerative Colitis.
.
Drug Saf. 42(5):617-632.
Battat R
,
Dulai PS
,
Casteele NVande
,
Evans E
,
Hester KD
,
Webster E
,
Jain A
,
Proudfoot JA
,
Mairalles A
,
Neill J
et al.
. 2019.
Biomarkers Are Associated With Clinical and Endoscopic Outcomes With Vedolizumab Treatment in Ulcerative Colitis.
.
Inflamm Bowel Dis. 25(2):410-420.
Gogokhia L
,
Buhrke K
,
Bell R
,
Hoffman B
,
D Brown G
,
Hanke-Gogokhia C
,
Ajami NJ
,
Wong MC
,
Ghazaryan A
,
Valentine JF
et al.
. 2019.
Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis.
.
Cell Host Microbe. 25(2):285-299.e8.
Battat R
,
Duijvestein M
,
Guizzetti L
,
Choudhary D
,
Boland BS
,
Dulai PS
,
Parker CE
,
Nguyen TM
,
Singh S
,
Casteele NVande
et al.
. 2019.
Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
.
Am J Gastroenterol. 114(5):733-745.
2018
Castellanos JG
,
Woo V
,
Viladomiu M
,
Putzel G
,
Lima S
,
Diehl GE
,
Marderstein AR
,
Gandara J
,
Perez AR
,
Withers DR
et al.
. 2018.
Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis.
.
Immunity. 49(6):1077-1089.e5.
Battat R
,
Duijvestein M
,
Casteele NVande
,
Singh S
,
Dulai PS
,
Valasek MA
,
Mimms L
,
McFarland J
,
Hester KD
,
Renshaw M
et al.
. 2018.
Serum Concentrations of 7α-hydroxy-4-cholesten-3-one Are Associated With Bile Acid Diarrhea in Patients With Crohn's Disease.
.
Clin Gastroenterol Hepatol.
2017
Battat R
,
Kopylov U
,
Bessissow T
,
Bitton A
,
Cohen A
,
Jain A
,
Martel M
,
Seidman E
,
Afif W
. 2017.
Association Between Ustekinumab Trough Concentrations and Clinical, Biomarker, and Endoscopic Outcomes in Patients With Crohn's Disease.
.
Clin Gastroenterol Hepatol. 15(9):1427-1434.e2.
Viladomiu M
,
Kivolowitz C
,
Abdulhamid A
,
Dogan B
,
Victorio D
,
Castellanos JG
,
Woo V
,
Teng F
,
Tran NL
,
Sczesnak A
et al.
. 2017.
IgA-coated enriched in Crohn's disease spondyloarthritis promote T17-dependent inflammation.
.
Sci Transl Med. 9(376)
J Blander M
,
Longman RS
,
Iliev ID
,
Sonnenberg GF
,
Artis D
. 2017.
Regulation of inflammation by microbiota interactions with the host.
.
Nat Immunol. 18(8):851-860.
Jacob V
,
Crawford C
,
Cohen-Mekelburg S
,
Viladomiu M
,
Putzel GG
,
Schneider Y
,
Chabouni F
,
OʼNeil S
,
Bosworth B
,
Woo V
et al.
. 2017.
Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
.
Inflamm Bowel Dis. 23(6):903-911.
Battat R
,
Kopylov U
,
Byer J
,
Sewitch MJ
,
Rahme E
,
Nedjar H
,
Zelikovic E
,
Dionne S
,
Bessissow T
,
Afif W
et al.
. 2017.
Vitamin B12 deficiency in inflammatory bowel disease: a prospective observational pilot study.
.
Eur J Gastroenterol Hepatol. 29(12):1361-1367.
2016
DeFilippis EM
,
Longman R
,
Harbus M
,
Dannenberg K
,
Scherl EJ
. 2016.
Crohn's Disease: Evolution, Epigenetics, and the Emerging Role of Microbiome-Targeted Therapies.
.
Curr Gastroenterol Rep. 18(3):13.
DeFilippis EM
,
Tabani S
,
Warren RU
,
Christos PJ
,
Scherl EJ
. 2016.
Exercise and Self-Reported Limitations in Patients with Inflammatory Bowel Disease.
.
Dig Dis Sci. 61(1):215-20.
Kivolowitz C
,
Abdulhamid A
,
Victorio D
,
Castellanos J
,
Simpson K
,
Scherl E
,
Longman R
. 2016.
O-006 Expansion of Immunologically-Relevant E. Coli in the Intestinal Microbiota of Patients with IBD-Associated Spondyloarthritis Promotes Mucosal RORgt-Dependent Immunity.
.
Inflamm Bowel Dis. 22 Suppl 1:S3.
2015
DeFilippis EM
,
Barfield E
,
Leifer D
,
Steinlauf A
,
Bosworth BP
,
Scherl EJ
,
Sockolow R
. 2015.
Cerebral venous thrombosis in inflammatory bowel disease.
.
J Dig Dis. 16(2):104-8.
Huang C
,
Haritunians T
,
Okou DT
,
Cutler DJ
,
Zwick ME
,
Taylor KD
,
Datta LW
,
Maranville JC
,
Liu Z
,
Ellis S
et al.
. 2015.
Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans.
.
Gastroenterology. 149(6):1575-86.
Chen HJoyce
,
Sun J
,
Huang Z
,
Hou H
,
Arcilla M
,
Rakhilin N
,
Joe DJ
,
Choi J
,
Gadamsetty P
,
Milsom J
et al.
. 2015.
Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targeting.
.
Nat Biotechnol. 33(6):656-60.
Gerbarg PL
,
Jacob VE
,
Stevens L
,
Bosworth BP
,
Chabouni F
,
DeFilippis EM
,
Warren R
,
Trivellas M
,
Patel PV
,
Webb CD
et al.
. 2015.
The Effect of Breathing, Movement, and Meditation on Psychological and Physical Symptoms and Inflammatory Biomarkers in Inflammatory Bowel Disease: A Randomized Controlled Trial.
.
Inflamm Bowel Dis. 21(12):2886-96.
Longman RS
,
Littman DR
. 2015.
The functional impact of the intestinal microbiome on mucosal immunity and systemic autoimmunity.
.
Curr Opin Rheumatol. 27(4):381-7.
Kiuru M
,
Camp B
,
Adhami K
,
Jacob V
,
Magro C
,
Wildman H
. 2015.
Treatment of metastatic cutaneous Crohn disease with certolizumab.
.
Dermatol Online J. 21(11)
Dassopoulos T
,
Cohen RD
,
Scherl EJ
,
Schwartz RM
,
Kosinski L
,
Regueiro MD
. 2015.
Ulcerative Colitis Care Pathway.
.
Gastroenterology. 149(1):238-45.
Hirten R
,
Longman RS
,
Bosworth BP
,
Steinlauf A
,
Scherl E
. 2015.
Vedolizumab and Infliximab Combination Therapy in the Treatment of Crohn's Disease.
.
Am J Gastroenterol. 110(12):1737-8.
2014
Longman RS
,
Diehl GE
,
Victorio DA
,
Huh JR
,
Galan C
,
Miraldi ER
,
Swaminath A
,
Bonneau R
,
Scherl EJ
,
Littman DR
. 2014.
CX₃CR1⁺ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22.
.
J Exp Med. 211(8):1571-83.
Zhang N
,
Yantiss RK
,
Nam H-S
,
Chin Y
,
Zhou XKathy
,
Scherl EJ
,
Bosworth BP
,
Subbaramaiah K
,
Dannenberg AJ
,
Benezra R
. 2014.
ID1 is a functional marker for intestinal stem and progenitor cells required for normal response to injury.
.
Stem Cell Reports. 3(5):716-24.
1
(current)
2
3
next ›
last »